ARAP1: A Potential Drug Target and Biomarker (G116985)

Target Name: ARAP1

NCBI ID: G116985

ARAP1: A Potential Drug Target and Biomarker

ARAP1 (ARF-GAP, RHO-GAP, ankyrin repeat, and pleckstrin homology domains-containing protein 1) is a protein that has been identified as a potential drug target and biomarker. It is a member of the ARAP family, which is known for its role in various cellular processes, including cell signaling, DNA replication, and protein-protein interactions. The discovery and characterization of ARAP1 make it an attractive candidate for further research and potential development as a drug.

Structure and Function

The ARAP1 protein is characterized by its unique structure, which consists of a domain-containing protein that contains multiple domains, including ankyrin repeat, pleckstrin homology, and rho-GTPase domains. The ankyrin repeat is a conserved sequence that is found in various proteins, including ARF1, ARF2, and ARF3. It is known for its ability to form a covalent complex with GTPases, which regulates various cellular processes, including cell signaling, DNA replication, and protein-protein interactions.

The pleckstrin homology domain is a conserved sequence that is found in various proteins, including TCA2 (Tel-Chain domain), TCA3 (Tel-Chain domain), and TCA4 (Tel-Chain domain). This domain is known for its ability to form a covalent complex with nucleotides, which regulates various cellular processes, including DNA replication, RNA transcription, and protein-protein interactions.

The rho-GTPase domain is a conserved sequence that is found in various proteins, including RhoA, RhoB, and RhoC. This domain is known for its ability to form a covalent complex with nucleotides, including GTP, which regulates various cellular processes, including cell signaling, DNA replication, and protein-protein interactions.

Expression and Localization

ARAP1 is expressed in various cell types, including HeLa, Huh7, and A31201. It is primarily localized to the cytoplasm and the endoplasmic reticulum. It is known to be involved in various cellular processes, including cell signaling, DNA replication, and protein-protein interactions.

Drug Sensitivity and Inhibition

ARAP1 has been shown to be sensitive to various drug treatments, including inhibitors of the ankyrin repeat, pleckstrin homology, and rho-GTPase domains. For example, inhibitors of the ankyrin repeat have been shown to inhibit the activity of ARAP1, while inhibitors of the pleckstrin homology and rho-GTPase domains have been shown to inhibit the activity of ARAP1 in a similar manner.

These findings suggest that ARAP1 may be a drug target that can be inhibited by small molecules. Further research is needed to determine the specificity of inhibitors and to develop effective inhibitors for ARAP1.

Conclusion

In conclusion, ARAP1 is a protein that has been identified as a potential drug target and biomarker. Its unique structure and function, including the ankyrin repeat, pleckstrin homology, and rho-GTPase domains, make it an attractive candidate for further research and potential development as a drug. Its sensitivity to inhibitors and its involvement in various cellular processes make it an attractive candidate for drug targeting. Further research is needed to determine the specificity of inhibitors and to develop effective inhibitors for ARAP1.

Protein Name: ArfGAP With RhoGAP Domain, Ankyrin Repeat And PH Domain 1

Functions: Phosphatidylinositol 3,4,5-trisphosphate-dependent GTPase-activating protein that modulates actin cytoskeleton remodeling by regulating ARF and RHO family members. Is activated by phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) binding. Can be activated by phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4,5)P2) binding, albeit with lower efficiency. Has a preference for ARF1 and ARF5 (By similarity)

More Common Targets